Center for Shoulder, Elbow, and Sports Medicine, Department of Orthopaedic Surgery, Columbia University Medical Center, New York Presbyterian Hospital, New York, New York, U.S.A..
Center for Shoulder, Elbow, and Sports Medicine, Department of Orthopaedic Surgery, Columbia University Medical Center, New York Presbyterian Hospital, New York, New York, U.S.A.
Arthroscopy. 2018 Feb;34(2):414-420. doi: 10.1016/j.arthro.2017.08.286. Epub 2017 Dec 19.
To analyze (1) the incidence and type of complications after elbow arthroscopy, (2) the incidence of returning to the operating room (OR) after elbow arthroscopy, and (3) patient and risk factors for complications across a national surgical outcome database.
Patients who underwent elbow arthroscopy from January 2005 through December 2014 were identified in the American College of Surgeons National Surgical Quality Improvement Program database by use of Current Procedural Terminology codes. Basic patient demographic data and medical comorbidities were recorded. Postoperative adverse events and a return to the OR occurring within 30 days after the index procedure were identified, and patient and procedural risk factors were investigated.
Five hundred thirty elbow arthroscopy cases were available for analysis. The aggregate rate of 30-day adverse events was 2.83%, whereas the rate of any patient having an adverse event was 1.89%. The most common adverse event was deep infection (0.57%). Univariate analyses showed that renal disease, preoperative steroid use, higher American Society of Anesthesiologists (ASA) class, and preoperative diagnosis were associated with the occurrence of an adverse event. Multivariate analyses showed that increasing ASA class, specifically ASA class 3 and class 4, was an independent predictor of a postoperative adverse event. Furthermore, 0.94% of cases required a return to the OR. Univariate analyses showed that preoperative steroid use and diagnosis of trauma were associated with a return to the OR. These findings were confirmed by multivariate analyses.
Overall, the incidence of 30-day postoperative adverse events (1.89%) and need to return to the OR (0.94%) is low. Increased ASA class is an independent risk factor for the occurrence of a postoperative adverse event; preoperative steroid use and diagnoses relating to a traumatic or inflammatory cause are predictive of the need to return to the OR. These results can assist surgeons in patient selection, preoperative optimization, and preoperative risk stratification.
Level IV, case series.
分析(1)肘关节镜术后并发症的发生率和类型,(2)肘关节镜术后重返手术室(OR)的发生率,以及(3)全国手术结果数据库中患者和并发症的风险因素。
在美国外科医师学会国家手术质量改进计划数据库中,通过使用当前程序术语 (CPT) 代码,确定了 2005 年 1 月至 2014 年 12 月期间接受肘关节镜手术的患者。记录了基本患者人口统计学数据和合并症。确定了索引手术后 30 天内发生的术后不良事件和重返 OR,并调查了患者和程序风险因素。
共有 530 例肘关节镜病例可供分析。30 天不良事件的总发生率为 2.83%,而任何患者发生不良事件的发生率为 1.89%。最常见的不良事件是深部感染(0.57%)。单因素分析表明,肾脏病、术前使用类固醇、较高的美国麻醉医师协会(ASA)分级和术前诊断与不良事件的发生有关。多因素分析表明,ASA 分级增加,特别是 ASA 分级 3 级和 4 级,是术后不良事件的独立预测因素。此外,0.94%的病例需要返回 OR。单因素分析表明,术前使用类固醇和创伤诊断与返回 OR 有关。这些发现通过多因素分析得到了证实。
总体而言,30 天术后不良事件(1.89%)和需要返回 OR(0.94%)的发生率较低。ASA 分级增加是术后不良事件发生的独立危险因素;术前使用类固醇和与创伤或炎症相关的诊断是需要返回 OR 的预测因素。这些结果可以帮助外科医生进行患者选择、术前优化和术前风险分层。
IV 级,病例系列。